Nerveda
1
6M
1
0.07
1
- Areas of investment
Summary
In 2007 was created Nerveda, which is appeared as Corporate Investor. The main department of described Corporate Investor is located in the San Diego. The fund was located in North America if to be more exact in United States.
Among the most popular fund investment industries, there are Life Science, Biotechnology. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight RetroSense Therapeutics.
The fund was created by Cam Gallagher.
The important activity for fund was in 2015. The usual things for fund are deals in the range of 5 - 10 millions dollars. The higher amount of exits for fund were in 2016. The fund is generally included in less than 2 deals every year.
The usual cause for the fund is to invest in rounds with 5 partakers. Despite the Nerveda, startups are often financed by Ann Arbor SPARK. The meaningful sponsors for the fund in investment in the same round are Tech Coast Angels, SDL Ventures, Michigan Economic Development Corporation. In the next rounds fund is usually obtained by Santen Pharmaceutical, RBV Capital, ExSight Ventures.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 0.07
- Investments by industry
- Genetics (1)
- Life Science (1)
- Biotechnology (1)
- Therapeutics (1)
- Investments by region
-
- United States (1)
- Peak activity year
- 2015
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 12
- Avg. valuation at time of investment
- 60M
- Group Appearance index
- 1.00
- Avg. company exit year
- 7
- Avg. multiplicator
- 3.53
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| RetroSense Therapeutics | 08 Jan 2015 | Biotechnology, Genetics, Life Science, Therapeutics | Early Stage Venture | 6M | United States, Ann Arbor, Michigan |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.